PHARMACOECONOMIC RESEARCH AND CLINICAL-TRIALS - CONCEPTS AND ISSUES

被引：17

作者：

BOOTMAN, JL

LARSON, LN

MCGHAN, WF

TOWNSEND, RJ

机构：

[1] UNIV ARIZONA,COLL PHARM,TUCSON,AZ 85721

[2] GLAXO INC,CLIN APPLICAT,RES TRIANGLE PK,NC

来源：

DICP-THE ANNALS OF PHARMACOTHERAPY | 1989年 / 23卷 / 09期

关键词：

D O I：

10.1177/106002808902300913

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：693 / 697

页数：5

共 22 条

[1]

ADAMS JG, 1983, SOCIETAL IMPACT PHAR

[2]

Bootman J L, 1979, Eval Health Prof, V2, P129, DOI 10.1177/016327877900200202

[3] INDIVIDUALIZING GENTAMICIN DOSAGE REGIMENS IN BURN PATIENTS WITH GRAM-NEGATIVE SEPTICEMIA - COST-BENEFIT-ANALYSIS [J].

BOOTMAN, JL ;

WERTHEIMER, AI ;

ZASKE, D ;

ROWLAND, C .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (03) :267-272

[4] COST OF INDIVIDUALIZING AMINOGLYCOSIDE DOSAGE REGIMENS [J].

BOOTMAN, JL ;

ZASKE, DE ;

WERTHEIMER, AI ;

ROWLAND, C .

AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1979, 36 (03) :368-370

[5]

Crystal R.A., 1966, INQUIRY, V3, P3

[6] COST-EFFECTIVENESS OF PHARMACEUTICALS .5. COST-BENEFIT AND COST-EFFECTIVENESS ANALYSIS OF DRUG-THERAPY [J].

DAO, TD .

AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1985, 42 (04) :791-802

[7]

DAO TD, 1983, COST BENEFIT COST EF

[8]

Drummond MF, 1986, METHODS EC EVALUATIO

[9] GUIDELINES FOR THE CLINICAL AND ECONOMIC-EVALUATION OF HEALTH-CARE TECHNOLOGIES [J].

GUYATT, G ;

DRUMMOND, M ;

FEENY, D ;

TUGWELL, P ;

STODDART, G ;

HAYNES, RB ;

BENNETT, K ;

LABELLE, R .

SOCIAL SCIENCE & MEDICINE, 1986, 22 (04) :393-408

[10]

HAAGA JG, 1983, COST EFFECTIVENESS C

← 1 2 3 →